Previous close | 10.10 |
Open | 10.23 |
Bid | 9.93 x 100 |
Ask | 10.05 x 100 |
Day's range | 9.80 - 10.23 |
52-week range | 1.81 - 15.05 |
Volume | |
Avg. volume | 261,488 |
Market cap | 383.544M |
Beta (5Y monthly) | 1.94 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Solid Biosciences' (SLDB) novel gene-therapy candidate, SGT-003, gets FDA's Rare Pediatric Disease Designation for the treatment of Duchenne muscular dystrophy.
In this article, we will take a detailed look at 14 Stocks With Heavy Insider Buying In 2024. For a quick overview of such stocks, read our article 5 Stocks With Heavy Insider Buying In 2024. Markets await latest inflation numbers and the debate regarding soft vs hard landing is expected to persist in the Wall Street for months […]
Vertex (VRTX), CRSP and Allakos are in the spotlight on regulatory and pipeline updates.